Literature DB >> 2896830

Tumour necrosis factor as an autocrine tumour growth factor for chronic B-cell malignancies.

F T Cordingley1, A Bianchi, A V Hoffbrand, J E Reittie, H E Heslop, A Vyakarnam, M Turner, A Meager, M K Brenner.   

Abstract

Recombinant tumour necrosis factor (TNF) promotes survival and induces proliferation in the tumour cells from two malignancies of B lymphocytes--hairy-cell leukaemia and B-chronic lymphocytic leukaemia. Culture with TNF also induces TNF mRNA and protein, so the cytokine may act as an autocrine tumour growth factor. These growth promoting effects are antagonised by alpha but not by gamma interferon.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2896830     DOI: 10.1016/s0140-6736(88)91782-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  38 in total

1.  Serum levels of interleukin-6 in multiple myeloma and other hematological disorders: correlation with disease activity and other prognostic parameters.

Authors:  D M Nachbaur; M Herold; A Maneschg; H Huber
Journal:  Ann Hematol       Date:  1991 Feb-Mar       Impact factor: 3.673

2.  Genetic variants in TNF-α promoter are predictors of recurrence in patients with squamous cell carcinoma of oropharynx after definitive radiotherapy.

Authors:  Caiyun Zhang; Erich M Sturgis; Hongliang Zheng; Xicheng Song; Peng Wei; Lei Jin; Li Chao; Qingyi Wei; Guojun Li
Journal:  Int J Cancer       Date:  2013-10-24       Impact factor: 7.396

3.  IL-2, IL-4, IFN-γ or TNF-α enhances BAFF-stimulated cell viability and survival by activating Erk1/2 and S6K1 pathways in neoplastic B-lymphoid cells.

Authors:  Lin Gui; Qingyu Zeng; Zhigang Xu; Hai Zhang; Shanshan Qin; Chunxiao Liu; Chong Xu; Zhou Qian; Shuangquan Zhang; Shile Huang; Long Chen
Journal:  Cytokine       Date:  2016-05-25       Impact factor: 3.861

4.  The mononuclear cell infiltrate compared with survival in high-grade astrocytomas.

Authors:  M L Rossi; N R Jones; E Candy; J A Nicoll; J S Compton; J T Hughes; M M Esiri; T H Moss; F F Cruz-Sanchez; H B Coakham
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

5.  Gene expression of cytokines suppressing hematopoietic progenitor cells in lymphoid malignancies.

Authors:  C Kawasaki; S Okamura; S Hayashi; S Kondo; M Harada; Y Niho
Journal:  J Cancer Res Clin Oncol       Date:  1991       Impact factor: 4.553

6.  TNF-α promoter polymorphisms and risk of recurrence in patients with squamous cell carcinomas of the nonoropharynx.

Authors:  Caiyun Zhang; Erich M Sturgis; Hongliang Zheng; Mark E Zafereo; Qingyi Wei; Guojun Li
Journal:  Int J Cancer       Date:  2014-02-27       Impact factor: 7.396

7.  Increased expression of interferon-gamma in hyperplastic lymph nodes from HIV-infected patients.

Authors:  M J Boyle; M F Berger; M Tschuchnigg; J E Valentine; B G Kennedy; M Divjak; D A Cooper; J J Turner; R Penny; W A Sewell
Journal:  Clin Exp Immunol       Date:  1993-04       Impact factor: 4.330

8.  Interleukin-6 functions as an intracellular growth factor in hairy cell leukemia in vitro.

Authors:  B Barut; D Chauhan; H Uchiyama; K C Anderson
Journal:  J Clin Invest       Date:  1993-11       Impact factor: 14.808

9.  Human herpesvirus 6 induces interleukin-1 beta and tumor necrosis factor alpha, but not interleukin-6, in peripheral blood mononuclear cell cultures.

Authors:  L Flamand; J Gosselin; M D'Addario; J Hiscott; D V Ablashi; R C Gallo; J Menezes
Journal:  J Virol       Date:  1991-09       Impact factor: 5.103

10.  CD23 antigen regulation and signaling in chronic lymphocytic leukemia.

Authors:  S Fournier; G Delespesse; M Rubio; G Biron; M Sarfati
Journal:  J Clin Invest       Date:  1992-04       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.